Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 27:11:23743735241241176.
doi: 10.1177/23743735241241176. eCollection 2024.

Barriers and Facilitators of Medication Adherence in Hypertension Patients: A Meta-Integration of Qualitative Research

Affiliations

Barriers and Facilitators of Medication Adherence in Hypertension Patients: A Meta-Integration of Qualitative Research

Xueying Zhou et al. J Patient Exp. .

Abstract

The aim of this qualitative systematic review is to analyze the barriers and facilitators to the uptake of antihypertensive medication in hypertensive patients. The databases of PubMed, Embase, Web of Science, CINAHL, Cochrane Library, MEDLINE, China National Knowledge Infrastructure, Wanfang, VIP, and Chinese Biomedical were searched from inception to June 2023. The studies were screened, extracted, and assessed independently by two researchers. Previously, the researchers used the Joanna Briggs Institute Critical Appraisal Checklist for Qualitative Research to assess the quality of the included studies. A total of 27 studies were considered, resulting in two combined findings: a good level of knowledge, belief, and behavior and adequate social support were facilitators of medication adherence in hypertensive patients. In contrast, lack of medication literacy, difficulty adapting to roles, reduced sense of benefit from treatment, limited access to healthcare resources, and unintentional nonadherence were barriers. Medication adherence in hypertensive patients remains a challenge to be addressed. Future research should explore how complex interventions using a combination of evidence-based strategies and targeting multiple adherence behaviors (eg, long-term adherence to medication) are effective in improving medication adherence.

Keywords: hypertension; influencing factors; medication adherence; meta integration; qualitative research.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The preferred reporting items for systematic reviews and meta-analyses (PRISMA) flowchart for the inclusion of studies.

Similar articles

References

    1. Zhou B, Carrillo-Larco RM, Danaei G, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957-980. doi:10.1016/S0140-6736(21)01330-1 - DOI - PMC - PubMed
    1. Murray CJL, Aravkin AY, Zheng P, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1223-1249. doi:10.1016/S0140-6736(20)30752-2 - DOI - PMC - PubMed
    1. Tajeu GS, Tsipas S, Rakotz M, et al. Cost-Effectiveness of recommendations from the surgeon general's call-to-action to control hypertension. Am J Hypertens. 2022;35(3):225-231. doi:10.1093/ajh/hpab162 - DOI - PMC - PubMed
    1. Unger T, Borghi C, Charchar F, et al. 2020 International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334-1357. doi:10.1161/HYPERTENSIONAHA.120.15026 - DOI - PubMed
    1. Andualem A, Liknaw T, Edmealem A, et al. Adherence to antihypertensive medications among adult hypertensive patients attending chronic follow-up units of Dessie referral hospital, northeastern Ethiopia: a cross-sectional study. Medicine. 2021;100(31):e26818. doi:10.1097/MD.0000000000026818 - DOI - PMC - PubMed

LinkOut - more resources